Genomic Insights / Industry Insights

WuXi NextCODE Welcomes Rob Brainin as EVP & Chief Operating Officer

Rob Brainin, EVP and chief operating officer of WuXi NextCODE

Brainin joins the company from Illumina, where he was Vice President and General Manager of Life Sciences and Applied Genomics.

On September 13, 2017, WuXi NextCODE announced the appointment of Rob Brainin as Executive Vice President and Chief Operating Officer. Brainin joins the company from Illumina, where he was Vice President and General Manager of Life Sciences and Applied Genomics.

“We are truly thrilled to welcome Rob on board. He is a key addition to our team and brings quite uniquely relevant experience for leading our global operations and commercial effort as we embark on the next phase in the growth of our platform,” said Hannes Smarason, CEO of WuXi NextCODE. “Rob understands genomics intimately and is skilled at listening to users and helping them to take advantage of sequence data to achieve their goals. I can’t think of a better person to build out our business and to leverage that growth to deliver ever more powerful consumer solutions – creating a network effect that enables everyone to benefit from the genome.”

WuXi NextCODE is at the center of the next phase of the genomics revolution, focusing on turning genomic data into actionable information that makes a difference to people’s lives. I am excited to be helping to enable all kinds of people everywhere to do just that.

“WuXi NextCODE is at the center of the next phase of the genomics revolution, focusing on turning genomic data into actionable information that makes a difference to people’s lives,” said Rob Brainin. “I am excited to be helping to enable all kinds of people everywhere to do just that, from the pharmaceutical company that is trying to discover new drugs, to doctors diagnosing rare diseases, and to individuals planning a family or just trying to understand what the future might hold for their health. That is what this platform is all about.”

Mr. Brainin has fifteen years’ experience leading the product development, market development and commercialization of life sciences and genomics technologies. At Illumina, he served as VP for the arrays business before becoming general manager of life sciences and applied genomics. Mr. Brainin also led business units at Invitrogen, Life Technologies and Thermo Fisher, and prior to that held leadership positions at Gateway Computing. He holds a BA in economics from Emory and began his career as a consultant with McKinsey & Co after attending Harvard Law School.

Alex Fowkes, who has served as COO since joining WuXi NextCODE from WuXi AppTec earlier in the year, has been named Chief Strategy Officer and EVP for Innovation. Having significantly built out the company’s global operations over the past six months, he will now oversee the growth and execution of key large-scale strategic projects that are expected to underpin much of the growth of the global platform. He will also focus on adding to the company’s portfolio of innovation and technologies, ensuring WuXi NextCODE stays at the forefront of the most advanced methods and approaches.